stem cell - Publications - Faculty & Research - Harvard Business School

Filter Results: (26)

Filter Results: (26)

Show Results For

Page 1 of 26 Results →

Sort by

Are you looking for?

→Search All HBS Web

Research Summary

The Business of Stem Cells

By: Debora L. Spar

In 2004, the topic of stem cell research made both medical and moral headlines. Buoyed by a series of technological breakthroughs, stem cell scientists grew increasingly convinced that they would eventually be able to use embryonic stem cells -- the pluripotent cells... View Details

January 2009 (Revised February 2009)
Case

Sydney IVF: Stem Cell Research

By: Robert L. Simons, Kathryn Rosenberg and Natalie Kindred

This case examines the strategy implementation and risk management decisions at Sydney IVF, a research-based in vitro fertilization and stem cell company based in Australia. Drs. Robert Jansen and Jock Anderson, who co-founded Sydney IVF in 1986, developed novel... View Details

Keywords: Ethics; Governing Rules, Regulations, and Reforms; Innovation and Management; Growth and Development Strategy; Risk Management; Genetics; Commercialization; Health Industry; Australia

November 2006 (Revised March 2008)
Case

The Harvard Stem Cell Institute

By: William A. Sahlman

Describes a set of issues confronting the leaders of the Harvard Stem Cell Institute, an innovative cross-university effort to accelerate scientific discovery and translation in the domain of stem cells. Covers a wide range of topics, including understanding how... View Details

Keywords: Talent and Talent Management; Higher Education; Entrepreneurship; Collaborative Innovation and Invention; Intellectual Property; Research and Development; Genetics; Biotechnology Industry; Health Industry; Massachusetts

June 2010 (Revised May 2017)
Teaching Note

Sydney IVF: Stem Cell Research

By: Robert Simons and Kathryn Rosenberg

Teaching Note for 109017. View Details

Keywords: Strategy And Execution; Management Control Systems; Levers Of Control; Strategy; Risk Management; Decisions; Cooperative Ownership; Product Development; Moral Sensibility; Governing Rules, Regulations, and Reforms; Expansion; Science-Based Business; Research; Management Practices and Processes; Business Subsidiaries; Biotechnology Industry; Sydney

2007
Article

Selling Stem Cell Science: How Markets Drive Law along the Technological Frontier

By: Debora Spar and Anna Harrington

Find at Harvard

January 2009 (Revised July 2010)
Case

iZumi

By: Robert F. Higgins, Jacob Ian Broder-Fingert, Eliot Sherman and Sidhartha Palani

Presents the issues faced while building an innovative company in an emerging space with new intellectual property from the perspective of a venture capitalist. Beth Seidenberg, a partner at the venture capital firm Kleiner Perkins Caufield & Byers (KPCB), had helped... View Details

Keywords: Entrepreneurship; Venture Capital; Globalized Markets and Industries; Innovation and Management; Intellectual Property; Rights; Genetics; Financial Services Industry; Health Industry

31 Jul 2007
First Look

First Look: July 31, 2007

small cell therapy start-up in Cambridge, Mass. If proven successful, Pervasis' product, Vascugel, could change the way vascular disease is treated and have a major impact in a large and underserved population. However, Vascugel had not... View Details

Keywords: Martha Lagace

September 2020
Case

Minerva 2010: Turbulent Times

By: John R. Wells and Benjamin Weinstock

In 2010, amid a flurry of new discoveries, Cynthia Bamdad, founder and CEO of Minerva Biotechnologies Corporation (Minerva), raised $6.6 million to test her new cancer drugs in mice. It had been more than 6 years since she had announced that she and her small team at... View Details

Keywords: Biotechnology; Research; Product Development; Commercialization; Strategy

19 Jun 2007
First Look

First Look: June 19, 2007

questions the appropriate role for the AHA and cause marketing. Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=507026 The Harvard Stem Cell Institute Harvard Business... View Details

Keywords: Martha Lagace

17 Dec 2007
Research & Ideas

The Rise of Medical Tourism

Southeast Asia. China frequently makes the news for stem cell therapies that are not allowed in the West. So while I think India has some unique features it is not strictly unique. Q: What are the recruiting... View Details

Keywords: by Martha Lagace; Health; Medical Devices & Supplies

Research Summary

Mastering Strategy Execution

By: Robert Simons

Professor Robert Simons’ research encompasses three areas of management accountability that are the foundation for successful strategy execution: organization design, performance measurement and control, and risk management. In addition, Simons is interested in the... View Details

05 Jan 2011
Op-Ed

Funding Unpredictability Around Stem-Cell Research Inflicts Heavy Cost on Scientific Progress

get money. If they can't get money, they lay off people and cancel projects. Now imagine you are a postdoc in a lab and are working on a project to use human embryonic stem cells to cure diabetes by creating... View Details

Keywords: by William Sahlman; Biotechnology; Health; Pharmaceutical

17 Dec 2001
Research & Ideas

Enterprising Women

people," said Cynthia Fisher (HBS MBA '90). In 1993, using her own capital, Fisher founded ViaCord, a business that allows customers to bank cord blood stem cells for possible future use in the... View Details

Keywords: by Julia Hanna

01 Sep 2009
First Look

First Look: September 1

the perspective of a venture capitalist. Beth Seidenberg, a partner at the venture capital firm Kleiner Perkins Caufield & Byers (KPCB), had helped create iZumi Bio, a company with ambitious prospects that she believed had the potential to become "the"... View Details

Keywords: Martha Lagace

29 May 2008
Research & Ideas

Global Change in the Built Environment

away with? We had sessions on innovation, real estate derivatives, the history of housing crises, trade deficits, the global economy, business ethics, stem cell research, and China's role in the new world... View Details

Keywords: by Arthur Segel; Construction; Real Estate

20 Feb 2008
First Look

First Look: February 20, 2008

provide evidence that they should self operates at a higher construal level (abstract, superordinate) than the want self, and that this difference in construal partly underlies previous future lock-in. Selling Stem View Details

Keywords: Martha Lagace

27 Aug 2008
Research & Ideas

Creating Leaders for Science-Based Businesses

facing leaders in those businesses." Another industry veteran, Professor of Management Practice Vicki Sato, led a discussion on "Emerging Models of University Research," with cases that looked at the Harvard-affiliated Whitesides Lab, View Details

Keywords: by Garry Emmons; Biotechnology; Health

13 Feb 2006
Research & Ideas

The Hidden Market for Babies

Meanwhile, those who are outside the market generally don't even know what's going on. Q: Are you worried that regulation could stifle innovation in reproductive medicines? A: Actually, I'm more worried about regulation in the stem View Details

Keywords: by Manda Salls; Biotechnology; Health; Technology

03 Mar 2009
First Look

First Look: March 3, 2009

the Primary Dealer Credit Facility (PDCF), the Term Securities Lending Facility (TSLF), and the Asset Backed Commercial Paper Money Market Mutual Fund Liquidity Facility (AMLF). Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=709041... View Details

Keywords: Martha Lagace

24 Mar 2020
Research & Ideas

These Coronavirus Heroes Show Us How Crisis Leadership Works

for COVID-19 and is currently able to run 1,000 tests per day. David A. Ricks, CEO of Eli Lilly. Under Ricks’ guidance, Lilly has teamed with AbCellera Biologics to find antibodies to disarm COVID-19. Looking for the correct antibody sequence, they have screened 5... View Details

Keywords: by Bill George; Health

1
2
→